105 related articles for article (PubMed ID: 1778876)
1. Correlation of in-vitro parameters of antimicrobial activity with prophylactic efficacy in an intradermal model of Staphylococcus aureus infection.
Warren MD; Kernodle DS; Kaiser AB
J Antimicrob Chemother; 1991 Nov; 28(5):731-40. PubMed ID: 1778876
[TBL] [Abstract][Full Text] [Related]
2. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
Kernodle DS; Classen DC; Burke JP; Kaiser AB
JAMA; 1990 Feb; 263(7):961-6. PubMed ID: 2299764
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.
Kernodle DS; Kaiser AB
Antimicrob Agents Chemother; 1993 Apr; 37(4):702-7. PubMed ID: 8494364
[TBL] [Abstract][Full Text] [Related]
4. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
Chapman SW; Steigbigel RT
J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection.
Kernodle DS; Voladri RK; Kaiser AB
J Infect Dis; 1998 Mar; 177(3):701-6. PubMed ID: 9498450
[TBL] [Abstract][Full Text] [Related]
7. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
Goldman PL; Petersdorf RG
J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
[TBL] [Abstract][Full Text] [Related]
8. Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce beta-lactamase.
Watts JL; Salmon SA
J Dairy Sci; 1997 Apr; 80(4):788-91. PubMed ID: 9149974
[TBL] [Abstract][Full Text] [Related]
9. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
10. beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.
Fields MT; Herndon BL; Bamberger DM
Antimicrob Agents Chemother; 1993 Feb; 37(2):203-6. PubMed ID: 8452349
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal.
Ariano RE; Zhanel GG
DICP; 1991 May; 25(5):478-84. PubMed ID: 2068834
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Hara T; Araake M; Tsuruoka T; Watabe H
Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
[TBL] [Abstract][Full Text] [Related]
13. The intramammary efficacy of first generation cephalosporins against Staphylococcus aureus mastitis in mice.
Demon D; Ludwig C; Breyne K; Guédé D; Dörner JC; Froyman R; Meyer E
Vet Microbiol; 2012 Nov; 160(1-2):141-50. PubMed ID: 22677480
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.
Baddour LM; Hill MM; Felty-Duckworth AM
Infection; 1989; 17(2):90-6. PubMed ID: 2714864
[TBL] [Abstract][Full Text] [Related]
15. Cefuroxime versus cefazolin as prophylaxis in vascular surgery.
Edwards WH; Kaiser AB; Kernodle DS; Appleby TC; Edwards WH; Martin RS; Mulherin JL; Wood CA
J Vasc Surg; 1992 Jan; 15(1):35-41; discussion 41-2. PubMed ID: 1728688
[TBL] [Abstract][Full Text] [Related]
16. Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.
Farrar WE; Gramling PK
J Infect Dis; 1976 Jun; 133(6):691-5. PubMed ID: 1047087
[TBL] [Abstract][Full Text] [Related]
17. Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection.
Kernodle DS; Kaiser AB
J Infect Dis; 1993 Jul; 168(1):152-7. PubMed ID: 8515103
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection.
Kernodle DS; Gates H; Kaiser AB
Antimicrob Agents Chemother; 1998 Mar; 42(3):545-9. PubMed ID: 9517930
[TBL] [Abstract][Full Text] [Related]
19. Role of beta-lactamase of methicillin-susceptible Staphylococcus aureus in resistance to first-generation oral cephems both in vitro and in vivo.
Takenouchi T; Utsui Y; Ohya S; Nishino T
J Antimicrob Chemother; 1994 Dec; 34(6):909-20. PubMed ID: 7730234
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
Lepak AJ; Andes DR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
